Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...
Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...
Abstract: Reduced weight, size, and maintenance cost, as well as quieter and eco-friendly operation of electro-mechanical actuators (EMA), gained profound attention in various sectors, particularly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results